ALLMedicine™ Type 2 Diabetes Center

Jan 19th, 2021 - Excess mortality in people with vs without type 2 diabetes (T2DM) has fallen, but it is unclear whether men/women at all ages have benefited and which causes of death have driven these trends. All-cause and cause-specific mortality rates and exces...

Jan 19th, 2021 - The incidence of type 2 diabetes (T2DM) among younger women now accounts for 40% of females with T2DM. Women of reproductive age with T2DM have additional health considerations and their needs may differ from older populations. To identify the hea...

Jan 19th, 2021 - Worldwide cardiovascular disease is the major cause of disability and premature death. This is due to the ascending trend of consuming an unhealthy diet and obesity which increases the risk of hypertension and type 2 diabetes mellitus. Thus this s...

Jan 19th, 2021 - To assess the relationship between growth differentiation factor-15 (GDF-15) levels and estimated glomerular filtration rate (eGFR) in type 2 diabetes mellitus (DM) patients with and without albuminuria. We examined 324 patients with type 2 DM in ...

Jan 19th, 2021 - To access the adequacy of treatment decisions in accordance with current recommendations for individualizing glycemic targets in primary and tertiary care. This multicenter cross-sectional study was conducted with a cohort of older type 2 diabetes...

Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...

Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...

Oct 8th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Sep 16th, 2020 - A recent network meta-analysis of 450 randomized clinical trials demonstrated various benefits of some newer pharmacologic diabetes agents (NEJM JW Gen Med Aug 1 2020 and Ann Intern Med 2020; 173:278). Based on these and other data, the ADA recent...

Aug 31st, 2020 - The American Diabetes Association (ADA) updates the Standards of Medical Care in Diabetes annually to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and managem...

Jan 31st, 2021 - Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Metformin hydrochloride extended-release tablets are a biguanide indicated as an...

Jan 19th, 2021 - Excess mortality in people with vs without type 2 diabetes (T2DM) has fallen, but it is unclear whether men/women at all ages have benefited and which causes of death have driven these trends. All-cause and cause-specific mortality rates and exces...

Jan 19th, 2021 - The incidence of type 2 diabetes (T2DM) among younger women now accounts for 40% of females with T2DM. Women of reproductive age with T2DM have additional health considerations and their needs may differ from older populations. To identify the hea...

Jan 19th, 2021 - Worldwide cardiovascular disease is the major cause of disability and premature death. This is due to the ascending trend of consuming an unhealthy diet and obesity which increases the risk of hypertension and type 2 diabetes mellitus. Thus this s...

Jan 19th, 2021 - To assess the relationship between growth differentiation factor-15 (GDF-15) levels and estimated glomerular filtration rate (eGFR) in type 2 diabetes mellitus (DM) patients with and without albuminuria. We examined 324 patients with type 2 DM in ...

Jan 18th, 2021 - Patients with type 2 diabetes who follow a low carbohydrate diet (LCD) for at least 6 months appear to have significantly higher remission rates than those following other diets, although the benefits diminish by 12 months, suggests a new analysis...

Jan 17th, 2021 - Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors during acute COVID-19 illness raises the risk for euglycemic diabetic ketoacidosis (euDKA), a new case series suggests. Five patients with type 2 diabetes who were taking SGLT2 inhibitors pr...

Jan 17th, 2021 - Takeaway Ultra-processed food (UPF) consumption was associated with a clinically important increased risk of type 2 diabetes (T2D). The risk of incident T2D increased by 12% for every 10 percentage points increase in UPF consumption. Why this matt...

Jan 14th, 2021 - The Food and Drug Administration has determined that data collected on the dual SGLT1/2 inhibitor sotagliflozin (Zynquista) for treating patients with type 2 diabetes in the SOLOIST and SCORED pivotal trials can help support a New Drug Application...

Jan 13th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The American Diabetes Association (ADA), along with 18 other organizations, has sent a letter to the US Centers for Disease Control and Prevention...